Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

A Rare Presentation of Primary Small-cell Carcinoma of Urinary Bladder

Munawwar Hussain*, Ahmed Khalil, Nazish Malik

Department of Internal Medicine, Conemaugh Health System, Johnstown PA 15905, USA

Abstract: Primary small cell carcinoma of urinary bladder is rare and aggressive neuroendocrine tumor. It is part of neuroendocrine tumor family that affects respiratory system, gastro intestinal tract and genitourinary system of male and female. We report a case of primary small cell carcinoma of urinary bladder treated with chemotherapy. Patient is 81 year old male who presented to emergency department with recurrent urinary retention associated with hematuria. Patient had cystoscopy and was diagnosed with small cell carcinoma of urinary bladder with no distant metastasis. Patient was treated with chemotherapy. Patient died with septic shock due to clostridium difficile colitis.

Keywords: small cell, cystoscopy, clostridium difficile colitis

Received April 17, 2019; Revised May 24, 2019; Accepted July 09, 2019

Citation: Munawwar Hussain, Ahmed Khalil, Nazish Malik, A Rare Presentation of Primary Small-cell Carcinoma of Urinary Bladder. American Journal of Medical Case Reports, 7 (8). 160-161. January 2019. doi:10.12691/ajmcr-7-8-2

1. Introduction

Small cell carcinoma of urinary bladder is rare, poorly differentiated neuroendocrine tumor of urinary bladder. It is also called oat cell carcinoma. It has poor prognosis as compared to urothelial carcinoma of urinary bladder in spite of having same clinical presentation, demographics, risk factors and diagnostic approach. Small cell carcinoma of urinary bladder is extremely rare accounting for 0.5 -1% cases [1]. It is commonly seen in old population. Patient can present with painless hematuria or bladder irritation, abdominal pain and urinary obstruction. As it is rare, it is difficult to have case control study. Sometime, patient are misdiagnosed. It is important to collect data about small cell carcinoma of urinary bladder for better understanding of presentation, diagnostic plan, treatment and follow up.

2. Case Presentation

Patient is 81 year old male with history of atrial fibrillation, coronary artery disease, severe aortic stenosis, chronic diastolic congestive heart failure, congenital solitary kidney who presented to the emergency department with recurrent hematuria and urinary retention. In the emergency department, Foley catheter was placed. Patient was discharged home. Patient had urology follow up as outpatient. Patient had flexible cystoscopy that showed thrombus versus mass in urinary bladder. Later on, patient had rigid cystoscopy that showed bladder mass. Transurethral resection of urinary bladder tumor was performed. Histopathology report showed bladder high-grade carcinoma with neuroendocrine differentiation and necrosis admixed with blood clot, consistent with bladder Small Cell Carcinoma. Histochemical staining was positive for synaptophysin, chromogranin and p53 negative for CK 20 and p63. Patient had CT chest, CT abdomen and pelvis that was negative for any distant metastasis. Positron emission tomography scan was unremarkable. Patient was started on neoadjuvant chemotherapy including VP-16 and Carboplatin. Patient had two cycles of chemotherapy. Following his second cycle of chemotherapy patient developed clostridium difficile colitis. He was treated with oral vancomycin as well as intravenous metronidazole. Patient developed septic shock secondary to clostridium colitis, acute renal failure and died due to septic shock.

3. Discussion

Small cell carcinoma is poorly differential and aggressive neuroendocrine tumor. Most of the time small cell carcinoma of urinary bladder is mixed with other urothelial carcinoma, squamous cell carcinoma and adenocarcinoma of urinary bladder [2]. Our case had isolated small cell carcinoma of urinary bladder. In case of small cell carcinoma of urinary bladder, 5 year survival rate is less than 10 percent as reported in many case report [3]. Most common presenting symptoms are hematuria, ureteral obstruction, acute renal failure, increase urgency, frequency and recurrent urinary tract infection. It can present with carcinoid tumor, hypercalcemia and syndrome of inappropriate secretions. [4] Due to rarity of it, pathogenesis in not really understood. As patient does not has specific symptoms suggestive of small cell carcinoma of urinary bladder diagnosis is based on histopathology and immunochemical assays. Typical microscopically features of SCC include small, round or oval-shaped tumor cells, a nest-like structure, little cytoplasm, hyperchromatic nuclei, a rough granular karyosome and frequently occurring massive mitotic figures, and extensive necrosis. The immunohistochemical assay is positive for CgA and CK, and negative for epithelial membrane antigen, leukocyte common antigen, synaptophysin and CD56 [5]. Due to poorly differentiation, it can metastasize to other tissue very easily.

Small cell carcinoma of urinary bladder diagnosis mainly depends on preoperative biopsy of lesion and postoperative histopathological examination, such as measurements by light microscopy cell morphology, cell ultrastructure electron microscope examination, and immunohistochemical examination. Preoperative examinations must include CT or MRI scan, urine cytology and cystoscopy. Cytology of small cell carcinoma of urinary bladder can be similar as poorly differentiated squamous cell carcinoma, adenocarcinoma, and transitional cell carcinoma, so diagnostic identification relies on electron microscopy or immunohistochemistry [6]. Small cell carcinoma of urinary bladder can be misdiagnosed transitional cell carcinoma, inverted papilloma, and glandular cystitis. Since there are clear distinctions in treatment programs between SCCB and other bladder tumors, we should raise awareness of the disease and carefully check the tissue samples in order to avoid misdiagnosis, missed diagnosis, and delay of treatment timing.

Due to rarity of disease having no randomized controlled study there is no defined treatment for small cell carcinoma of urinary bladder. According to the experience of the Mayo Clinic (Rochester, MN, USA), a radical cystectomy should be applied to all SCBC patients unless there is metastasis (M1). [7] In literature review, we found evidence that TURBT alone was an inadequate method of control of the disease due to its aggressive nature, even in limited disease. Lynch and colleagues discovered that in combined treatment modalities (neoadjuvant chemotherapy+cystectomy versus cystectomy + adjuvant chemotherapy), the median overall survival was 159.5 months in the first group and 18.3 months in the latter [8]. In review of case report, there is documentation of treatment with immunotherapy PD1 inhibitor pembrolizumab who has significant response in clinical as well as radiographically but this needs further investigation [9].

4. Conclusion

Primary SCCB is a very rare and aggressive tumor. Local disease can be treated with Neoadjuvant chemotherapy, radiation and surgery. For distant disease the chemotherapy using a platinum agent is the mainstay of treatment. Patient was on oral anticoagulation, always look for secondary reason of hematuria or bleeding. Effectiveness of Immunotherapy in treatment of small cell carcinoma of urinary bladder needs to be assessed.

References

[1]   | Mustapha Ahsaini, Omar Riyach, Mohammed Fadl Tazi, Mohammed Jamal El Fassi, My Hassan Farih, Hind Elfatmi, and Afaf Amarti.. Small Cell Neuroendocrine Carcinoma of the Urinary Tract Successfully Managed with Neoadjuvant Chemotherapy.
[2]   | Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang S, Pan CX, Baldridge LA. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.
[3]   | Petrescu A, Berdan G, Hulea I, Gaitanidis R, Ambert V, Jinga V, Damian D, Codreanu O, Andrei F, Niculescu L. Small cell carcinoma of the urinary bladder--a new case report.
[4]   | WEN-TING OU, QI-LIAN LIANG, XIN HUANG, ZHOU-YU LI, and QIU-LONG LIU. Small cell carcinoma of the urinarybladder: A case report and review of the literature.
[5]   | Gon S, Majumdar B, Dey RK, Mitra SK. Pure primary small cell carcinoma of urinary bladder: A rare diagnostic entity. Urol Ann. 2013; 5:209-211.
[6]   | Bex A, Nieuwenhuijzen J, Kerst M. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology. 2005; 65: 295-9.
[7]   | Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
[8]   | Lynch SP, Vu TT, Kamat AM, Grossman HB, Millikan RE, Dinney CP, et al. The impact of neoadjuvant chemotherapy in small cell carcinoma of the bladder: The M. D. Anderson Cancer Center experience. J Clin Oncol. 2010; 28:15s. (suppl; abstr 4566).
[9]   | Lindsay Wilde, Siraj M. Ali, Charalambos C. Solomides, Jeffrey S. Ross. Clinical Genitourinary Cancer, 2017-06-01, Volume 15, Issue 3, Pages e521-e524, Copyright © 2016 Elsevier Inc.